There is a Dutch saying ‘When the first sheep crosses the gate…’.
Pharma-giant Pfizer definitely took a large step by crossing the line from the traditional ‘site-oriented’ trials to a full internet-based trial. Pfizer got approval from the FDA to ‘duplicate’ a 2007 study on a pill for overactive bladder syndrome (OAB) using the internet for both Patient recruitment and data-collection.
This years’ meeting will have more emphasis on the clinical aspects of drug research. Tuesday evening will even have dedicated sessions with Patient Organizations. One of the themes of this year’s meeting is interaction with Trial patients.
Visit our booth at the FIGON Dutch Medicines Days and see how Study-Portal can assist you in communicating with your Trial Subjects.
CTEAD Berlin 2011 will provide both the general population and medical practitioners access to information about the clinical research and clinical trial situation in Germany, shedding light on a subject that has so far been mostly unknown to them. It will encourage visitors to seek further information to be prepared for educated and informed decisions about clinical trial participation when the opportunity presents itself.
Beyond Recruitment: Involving Patients in Clinical Research
This conference as a part of the Clinical Trial Education and Awareness Days will enable you to discover and learn new approaches to meet patient recruitment challenges and avoid extending time-lines. Learn how to involve patients and their organizations in clinical research by satisfying their expectations.
Study-Portal will exhibit at the ‘Clinical Trial Education and Awareness days’ on June 16-18 in Berlin.
Please drop by and discuss with our team how we can assist you with ‘engaging’ Clinical Trial Subjects.
Study-Portal has been invited to present a workshop “How to use online tools for Trial Patient Engagement” during the ‘Clinical Trial Education and Awareness Days’ meeting in Berlin on June 16 – 18.
This interactive workshop will be discussing the ins and outs of using online tools to ‘engage’ and communicate with clinical trial patients in the different phases of a clinical study.
Most clinical studies use a ‘Site-centric’ approach for Trial Patient recruitment. Although this seems to work quite well for the more common disease categories (like diabetes or high blood pressure), it has reached its limitations for the more rare disease categories.
At the 2011 DataFax User Group meeting in Whistler, Pascal Groenen (Factory CRO) and Sjouke Huisman (Study-Portal) have presented the results from interfacing Clinical data and Study Metrics from DataFax clinical DBMS into the Clinical Study-Portal.